Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 23.81 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $34.454 million which beat the analyst consensus estimate of $34.183 million by 0.79 percent. This is a 7.75 percent increase over sales of $31.975 million the same period last year.